Literature DB >> 2200803

Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.

S Okuda1, L R Languino, E Ruoslahti, W A Border.   

Abstract

Glomerular accumulation of extracellular matrix is a prominent feature of progressive glomerulonephritis. Previously, we have shown that transforming growth factor-beta (TGF-beta) is unique among growth factors in regulating the production of the proteoglycans biglycan and decorin by glomerular mesangial cells in vitro. We now provide evidence of an elevated expression of TGF-beta, proteoglycans, and fibronectin in glomerulonephritis induced in rats by injection of anti-thymocyte serum (ATS). Glomeruli were cultured from rat kidneys at 1, 4, 7, 14, and 28 d after ATS administration. Increased proteoglycan synthesis was detected beginning on day 4, which peaked at a 4,900% increase compared with control on day 7, and returned toward control levels by day 28. The increased proteoglycan synthesis by cultured nephritic glomeruli, as well as that of fibronectin, were greatly reduced by addition of antiserum raised against a synthetic peptide from TGF-beta. Conditioned media from ATS glomerular cultures, when added to normal cultured mesangial cells, induced elevated proteoglycan synthesis that also peaked on day 7 and that mimicked the response to added exogenous TGF-beta. The stimulatory activity of the conditioned media was blocked by addition of TGF-beta antiserum. Prior addition of the immunizing peptide to the antiserum abolished the blocking effect. The main induced proteoglycans were identified as biglycan and decorin by immunoprecipitation with antiserum made against synthetic peptides from the proteoglycan core proteins. Glomerular histology showed mesangial matrix expansion in a time course that roughly paralleled both the elevated proteoglycan synthesis by the ATS glomeruli and the ability of the conditioned media from these glomeruli to induce proteoglycan synthesis. At the same time there was an increased expression of TGF-beta mRNA and TGF-beta protein in the glomeruli. These results suggest a central role for TGF-beta in the accumulation of pathological extracellular matrix in glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200803      PMCID: PMC296747          DOI: 10.1172/JCI114731

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.

Authors:  D A Rappolee; D Mark; M J Banda; Z Werb
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

2.  Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.

Authors:  J M Boswell; M A Yui; D W Burt; V E Kelley
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

3.  Transforming growth factor beta regulates the metabolism of proteoglycans in bovine cartilage organ cultures.

Authors:  T I Morales; A B Roberts
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

4.  Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences.

Authors:  L M Wakefield; D M Smith; K C Flanders; M B Sporn
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

5.  Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans.

Authors:  A Bassols; J Massagué
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

Review 6.  The progression of renal disease.

Authors:  S Klahr; G Schreiner; I Ichikawa
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

7.  Cell adhesion protein receptors as targets for transforming growth factor-beta action.

Authors:  R A Ignotz; J Massagué
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

8.  Antibodies to peptide determinants in transforming growth factor beta and their applications.

Authors:  K C Flanders; A B Roberts; N Ling; B E Fleurdelys; M B Sporn
Journal:  Biochemistry       Date:  1988-01-26       Impact factor: 3.162

9.  Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat.

Authors:  T Yamamoto; C B Wilson
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

10.  Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase.

Authors:  M Laiho; O Saksela; J Keski-Oja
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

View more
  113 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Kindlin-2 Association with Rho GDP-Dissociation Inhibitor α Suppresses Rac1 Activation and Podocyte Injury.

Authors:  Ying Sun; Chen Guo; Ping Ma; Yumei Lai; Fan Yang; Jun Cai; Zhehao Cheng; Kuo Zhang; Zhongzhen Liu; Yeteng Tian; Yue Sheng; Ruijun Tian; Yi Deng; Guozhi Xiao; Chuanyue Wu
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

3.  Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Authors:  Mauro Abbate; Carla Zoja; Marina Morigi; Daniela Rottoli; Stefania Angioletti; Susanna Tomasoni; Cristina Zanchi; Lorena Longaretti; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 4.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

Review 5.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 6.  Tubular and interstitial factors in the progression of glomerulonephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

7.  TGFβ acts through PDGFRβ to activate mTORC1 via the Akt/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression.

Authors:  Soumya Maity; Falguni Das; Balakuntalam S Kasinath; Nandini Ghosh-Choudhury; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

8.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Authors:  N Sanderson; V Factor; P Nagy; J Kopp; P Kondaiah; L Wakefield; A B Roberts; M B Sporn; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  L-arginine may mediate the therapeutic effects of low protein diets.

Authors:  I Narita; W A Border; M Ketteler; E Ruoslahti; N A Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

Authors:  T Yamamoto; T Nakamura; N A Noble; E Ruoslahti; W A Border
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.